Caligan Partners’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-310,298
Closed -$2.7M 13
2023
Q2
$2.7M Sell
310,298
-125,000
-29% -$1.09M 1.52% 9
2023
Q1
$1.28M Hold
435,298
0.89% 9
2022
Q4
$1.52M Buy
+435,298
New +$1.52M 1.27% 8